Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 540-546

  Margolis, D J ^a   Hoffstad, O ^a   Bilker, W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acne; Complications; Epidemiology; Lupus erythematosus; Tetracyclines

Indexed keywords

DOXYCYCLINE; ERYTHROMYCIN; MINOCYCLINE; OXYTETRACYCLINE; TETRACYCLINE;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HAZARD RATIO; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; COHORT STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MINOCYCLINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34547862772     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08056.x     Document Type: Article

References (28)

1. Gollnick H, Cunliffe W, Berson D et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2004 49 : S1 38.
2. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 1998 39 : S34 7.
3. Yeung CK, Teo LH, Xiang LH, Chan HH. A community-based epidemiological study of acne vulgaris in Hong Kong adolescents. Acta Derm Venereol (Stockh) 2002 82 : 104 7.
4. Stern RS. The prevalence of acne on the basis of physical examination. J Am Acad Dermatol 1992 26 : 931 5.
5. Silverberg NB, Weinberg JM. Rosacea and adult acne: a worldwide epidemic. Cutis 2001 68 : 85.
6. Stern RS. Medication and medical service utilization for acne 1995-1998. J Am Acad Dermatol 2000 43 : 1042 8.
7. Oberemok SS, Shalita AR. Acne vulgaris, II: treatment. Cutis 2002 70 : 111 4.
8. Margolis DJ, Bowe WP, Hoffstad O. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 2005 141 : 1132 6.
9. Skidmore R, Kovach R, Walker C et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003 139 : 459 64.
10. Leyden JJ. Therapy for acne vulgaris. N Engl J Med 1997 336 : 1156 62.
11. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 2001 15 (Suppl. 3 51 5.
12. McManus P, Iheanacho I. Don't use minocycline as first line oral antibiotics in acne. BMJ 2007 334 : 154.
13. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006 54 : 258 65.
14. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. A systematic review. Dermatology 2000 200 : 223 31.
15. Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med 1999 159 : 493 7.
16. Bachmeyer C, Cadranel JF. Minocycline-induced lupus and autoimmune hepatitis: family autoimmune disorders as possible risk factors. Dermatology 2002 205 : 185 6.
17. Lopez P, Mozo L, Gutierrez C, Suarez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003 12 : 860 5.
18. Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 2003 25 : 3 12.
19. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995 38 : 551 8.
20. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 1993 32 : 110 5.
21. D'Cruz DP. Systemic lupus erythematosus. BMJ 2006 332 : 890 4.
22. Gelfand JM, Berlin J, Van VA, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003 139 : 1425 9.
23. Gelfand JM, Margolis DJ, Dattani H. The UK General Practice Research Database. In : Pharmacoepidemiology (Strom BL, ed 3rd edn. Chichester : Wiley, 2005 337 46.
24. Margolis DJ, Knauss J, Bilker W. Medical conditions associated with venous leg ulcers in an outpatient. Br J Dermatol 2004 150 : 267 73.
25. Jick SS, Kaye JA, Vasilakis-Scaramozza C et al. Validity of the general practice research database. Pharmacotherapy 2003 23 : 686 9.
26. Mok CC, Lau CS, Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003 56 : 481 90.
27. Oberemok SS, Shalita AR. Acne vulgaris, I: pathogenesis and diagnosis. Cutis 2002 70 : 101 5.
28. Nightingale AL, Farmer RD, de Vries CS. Incidence of clinically diagnosed systemic lupus erythematous 1992-1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2006 15 : 656 61.